Meeting Patients Where They Are: Why Trust Matters

Patient support programs have steadily expanded , adding more channels, more touchpoints, and more digital tools designed to keep patients informed and on therapy. But the experience patients describe often tells a different story. Despite the investments in personalization tools, channel optimization, and deep analytics around engagement, many patients report feeling less connected to their support program over time, not more.

What appears to be missing is not capacity. It is trust. And trust, in patient support, is built through a narrower and more deliberate set of conditions than the industry’s current investment patterns might suggest.

The signal beneath the engagement numbers

Recent research points to the notion of trust as a correlating factor in engagement trends. Athena Health found that 89% of patients are more likely to engage when outreach comes from a recognizable, trusted sender, while 65% routinely ignore messages they perceive as generic or unclear.¹ Press Ganey reports that 47% of patients have delayed or avoided scheduling care due to communication frustrations, and 61% of those patients said the delay had a negative impact on their health.²

These are not preference metrics. They describe patients whose treatment was materially affected by communication that did not feel built for them. When outreach is layered without intention, patients often experience it as noise, and the program’s ability to reach them in the moments that matter declines accordingly. Even when communication is optimally personalized, the remaining element which must be solved for is the “recognizable, trusted sender”. As AI becomes more pervasive in our daily lives, the ability to screen for authenticity and make decisions about filtering signals from noise will place greater emphasis on building trust.

What patients consistently ask for

Across patient feedback, three priorities tend to appear consistently, regardless of therapy area or channel.

• Confidence to act. Patients who feel emotionally supported and informed are more likely to begin and continue therapy. Drawing on 10.5 million patient encounters, Press Ganey found that patients who report feeling “very safe” register an NPS of 85.3, more than 50 points higher than those who do not.² Perceived safety appears closely linked to whether a patient is willing to move forward with treatment at all.
• Clarity to navigate. When patients encounter fragmented systems or inconsistent information, they often interpret it as a sign that the program was not designed with them in mind. That perception is difficult to reverse once formed.
• Continuity of support. A consistent, trusted relationship across access, affordability, and adherence appears to outperform a series of disconnected interactions. Sciensus data indicates patients enrolled in a hybrid digital and nurse support model are nearly twice as likely to remain adherent compared to those receiving digital support alone.³

These priorities are interdependent. Confidence is difficult to build without clarity. Clarity loses its value without continuity. And continuity, on its own, cannot compensate for a program that has not established trust at the outset.

What trust-centered programs look like in practice

Manufacturers are beginning to revisit how their patient support programs are structured. They’re evaluating far more than channel mix. They’re evaluating where the human relationship sits within the overall design. The shift is less about adding new tactics and more about acknowledging that the patient relationship is what everything else should be built around.

The common elements are not novel, but they are intentional and operate as a continuum:

• CNE-led onboarding within hours of prescription, establishing a human point of contact before patient questions begin to compound
• Consistent nurse relationships across early therapy and key milestones, so patients aren’t re-explaining themselves at every turn
• Digital touchpoints positioned between live nurse interactions, extending continuity rather than replacing it
• Live access and benefits navigation that translates affordability and coverage into plain language
• Ongoing check-ins focused on the medication journey, surfacing emotional fatigue, fear, or frustration early
• Data-informed outreach that identifies adherence risk and equips nurses with insights to tailor follow-up

Engagement as a relationship, not a campaign

Specialty therapies are an increasing share of the market, and patient support investment has grown alongside them. That growth has expanded what programs are capable of doing, but capability has not always translated into a clearer experience for the patient. The programs that appear to have the most impact are not the ones with the most channels, but the ones where the human relationship is treated as the central design choice, with digital, AI, and analytics built to reinforce it.

Meeting patients where they are is not a tagline. It is a structural decision about where trust is built and who carries it. The question worth asking is whether today’s support programs are built around that relationship, or around the activity that surrounds it.

Sources

1. Athena Health
2. Press Ganey
3. Sciensus